192 related articles for article (PubMed ID: 25595279)
1. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer.
Gonzalez-Villasana V; Fuentes-Mattei E; Ivan C; Dalton HJ; Rodriguez-Aguayo C; Fernandez-de Thomas RJ; Aslan B; Del C Monroig P; Velazquez-Torres G; Previs RA; Pradeep S; Kahraman N; Wang H; Kanlikilicer P; Ozpolat B; Calin G; Sood AK; Lopez-Berestein G
Clin Cancer Res; 2015 May; 21(9):2127-37. PubMed ID: 25595279
[TBL] [Abstract][Full Text] [Related]
2. NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.
Xia P; Huang M; Zhang Y; Xiong X; Yan M; Xiong X; Yu W; Song E
Gynecol Oncol; 2019 Feb; 152(2):387-395. PubMed ID: 30442385
[TBL] [Abstract][Full Text] [Related]
3. Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer.
Previs RA; Armaiz-Pena GN; Lin YG; Davis AN; Pradeep S; Dalton HJ; Hansen JM; Merritt WM; Nick AM; Langley RR; Coleman RL; Sood AK
Mol Cancer Ther; 2015 Dec; 14(12):2677-86. PubMed ID: 26516159
[TBL] [Abstract][Full Text] [Related]
4. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
[TBL] [Abstract][Full Text] [Related]
5. Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis.
Khan S; Shukla S; Farhan M; Sinha S; Lakra AD; Penta D; Kannan A; Meeran SM
Life Sci; 2020 Sep; 256():117976. PubMed ID: 32561397
[TBL] [Abstract][Full Text] [Related]
6. Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells.
Atmaca H; Gorumlu G; Karaca B; Degirmenci M; Tunali D; Cirak Y; Purcu DU; Uzunoglu S; Karabulut B; Sanli UA; Uslu R
Eur Cytokine Netw; 2009 Sep; 20(3):121-30. PubMed ID: 19825521
[TBL] [Abstract][Full Text] [Related]
7. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
8. Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression.
Ory B; Baud'huin M; Verrecchia F; Royer BB; Quillard T; Amiaud J; Battaglia S; Heymann D; Redini F; Lamoureux F
Clin Cancer Res; 2016 May; 22(10):2520-33. PubMed ID: 26712686
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
10. Activation of endothelial ras-related C3 botulinum toxin substrate 1 (Rac1) improves post-stroke recovery and angiogenesis via activating Pak1 in mice.
Bu F; Min JW; Munshi Y; Lai YJ; Qi L; Urayama A; McCullough LD; Li J
Exp Neurol; 2019 Dec; 322():113059. PubMed ID: 31499064
[TBL] [Abstract][Full Text] [Related]
11. Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway.
Cheng H; Wang W; Wang G; Wang A; Du L; Lou W
Med Sci Monit; 2018 Feb; 24():768-781. PubMed ID: 29410394
[TBL] [Abstract][Full Text] [Related]
12. Microvascular endothelial cell responses in vitro and in vivo: modulation by zoledronic acid and paclitaxel?
Michailidou M; Brown HK; Lefley DV; Evans A; Cross SS; Coleman RE; Brown NJ; Holen I
J Vasc Res; 2010; 47(6):481-93. PubMed ID: 20431297
[TBL] [Abstract][Full Text] [Related]
13. Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.
Knight LA; Conroy M; Fernando A; Polak M; Kurbacher CM; Cree IA
Anticancer Drugs; 2005 Oct; 16(9):969-76. PubMed ID: 16162973
[TBL] [Abstract][Full Text] [Related]
14. Baicalein inhibits MMP-2 expression in human ovarian cancer cells by suppressing the p38 MAPK-dependent NF-κB signaling pathway.
Yan H; Xin S; Wang H; Ma J; Zhang H; Wei H
Anticancer Drugs; 2015 Jul; 26(6):649-56. PubMed ID: 25811965
[TBL] [Abstract][Full Text] [Related]
15. FER mediated HGF-independent regulation of HGFR/MET activates RAC1-PAK1 pathway to potentiate metastasis in ovarian cancer.
Fan G
Small GTPases; 2020 May; 11(3):155-159. PubMed ID: 29099290
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer.
Wu B; Hu K; Li S; Zhu J; Gu L; Shen H; Hambly BD; Bao S; Di W
Oncol Rep; 2012 Jan; 27(1):101-8. PubMed ID: 22025319
[TBL] [Abstract][Full Text] [Related]
17. p120-catenin participates in the progress of gastric cancer through regulating the Rac1 and Pak1 signaling pathway.
Li TF; Qin SH; Ruan XZ; Wang X
Oncol Rep; 2015 Nov; 34(5):2357-64. PubMed ID: 26324182
[TBL] [Abstract][Full Text] [Related]
18. Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.
Knight LA; Kurbacher CM; Glaysher S; Fernando A; Reichelt R; Dexel S; Reinhold U; Cree IA
BMC Cancer; 2009 Jan; 9():38. PubMed ID: 19175937
[TBL] [Abstract][Full Text] [Related]
19. The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.
Bäckman U; Svensson A; Christofferson RH; Azarbayjani F
Anticancer Res; 2008; 28(3A):1551-7. PubMed ID: 18630510
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway.
Chen QY; Zheng Y; Jiao DM; Chen FY; Hu HZ; Wu YQ; Song J; Yan J; Wu LJ; Lv GY
J Nutr Biochem; 2014 Feb; 25(2):177-85. PubMed ID: 24445042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]